Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial
Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page
- CheckyesterdayChange DetectedThe page metadata was updated to reflect a new revision (v3.6.3) and more recent update dates (2026-06-26 and 2026-06-29), indicating an administrative update to the study record.SummaryDifference0.2%

- Check8 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a software update to the page. No changes to the displayed study details or layout are evident from this revision.SummaryDifference0.0%

- Check15 days agoChange DetectedNew update dates (2026-06-17, 2026-06-16, 2026-06) were added and older dates (2026-04-16, 2026-04-13, 2026-04) were removed from the update history, signaling recent activity on the study page.SummaryDifference0.2%

- Check22 days agoChange DetectedNew helper links were added to the study page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the page’s revision tag was updated to v3.6.0; the Intervention heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check29 days agoChange DetectedThe page's revision label has been updated to v3.5.5, indicating a recent deployment of site updates.SummaryDifference0.0%

- Check51 days agoChange DetectedThe study record page shows a revision label updated from v3.5.3 to v3.5.4, indicating a small update to the page’s metadata. This change does not alter the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.